The International Weightlifting Federation (IWF) has decided not to suspend Lyaysan Makhiyanova, 2013 European Junior champion in 75 kilogram and Russian champion, for using banned drug Meldonium.
"The IWF reports that samples of Ms. Hripsime Khurshudyan (ARM), Ms. Lyaysan Makhiyanova (RUS), Mr. Krzysztof Szramiak (POL) have returned an Adverse Analytical Finding for (S4.5.3 Hormone and metabolic modulators) Meldonium," IWF said in a statement on Monday, reports Tass.
"The IWF decided not to suspend the aforementioned athletes provisionally," the report added noting that "in any case where it is determined that the athletes did not commit an anti-doping rule violation, the relevant decisions will also be published."
The World Anti-Doping Agency (WADA) announced on April 13 that the concentration of less than one microgram of Meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.
The drug Meldonium was included in the list of preparations banned by WADA from January 1, 2016. The presence of the Meldonium in an athlete's blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
Earlier, WADA said that a total of 172 athletes had tested positive for Meldonium.
Meldonium is used in sports for enhancing the human body's ability to resist physical strain during training sessions and nervous and psychological pressures during competitions. In some countries it is used as a pre-emptive drug against cardiovascular diseases.
The presence of this substance in the athlete's doping sample during and between competitions has been regarded as a violation of doping rules since January 1, 2016.
--IANS
sam/bg
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
